Clinical Chemistry
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 52: 1777-1784, 2006. First published June 22, 2006; 10.1373/clinchem.2005.063354
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
clinchem.2005.063354v1
52/9/1777    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (17)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by de Ronde, W.
Right arrow Articles by de Jong, F. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by de Ronde, W.
Right arrow Articles by de Jong, F. H.
Related Collections
Right arrow Endocrinology and Metabolism
(Clinical Chemistry. 2006;52:1777-1784.)
© 2006 American Association for Clinical Chemistry, Inc.


Endocrinology and Metabolism

Calculation of Bioavailable and Free Testosterone in Men: A Comparison of 5 Published Algorithms

Willem de Ronde1,3,a, Yvonne T. van der Schouw2, Huibert A.P. Pols3,4, Louis J.G. Gooren1, Majon Muller2, Diederick E. Grobbee2 and Frank H. de Jong3

1 Department of Endocrinology, Vrije Universiteit Medical Center, Amsterdam, The Netherlands.
2 Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, The Netherlands.
3 Departments of Internal Medicine; and 4 Epidemiology and Biostatistics, Erasmus Medical Center, Rotterdam, The Netherlands.

aAddress correspondence to this author at: Department of Endocrinology, VU University Medical Center, de Boelelaan 1117, P.O. Box 7057, 1007 MB Amsterdam, The Netherlands. E-mail p.deronde{at}vumc.nl.

Background: Estimation of serum concentrations of free testosterone (FT) and bioavailable testosterone (bioT) by calculation is an inexpensive and uncomplicated method. We compared results obtained with 5 different algorithms.

Methods: We used 5 different published algorithms [described by Sodergard et al. (bioTS and FTS), Vermeulen et al. (bioTV and FTV), Emadi-Konjin et al. (bioTE), Morris et al. (bioTM), and Ly et al. (FTL)] to estimate bioT and FT concentrations in samples obtained from 399 independently living men (ages 40–80 years) participating in a cross-sectional, single-center study.

Results: Mean bioT was highest for bioTS (10.4 nmol/L) and lowest for bioTE (3.87 nmol/L). Mean FT was highest for FTS (0.41 nmol/L), followed by FTV (0.35 nmol/L), and FTL (0.29 nmol/L). For bioT concentrations, the Pearson correlation coefficient was highest for the association between bioTS and bioTV (r = 0.98) and lowest between bioTM and bioTE (r = 0.66). FTL was significantly associated with both FTS (r = 0.96) and FTV (r = 0.88). The Pearson correlation coefficient for the association between FTL and bioTM almost reached 1.0. Bland-Altman analysis showed large differences between the results of different algorithms. BioTM, bioTE, bioTV, and FTL were all significantly associated with sex hormone binding globulin (SHBG) concentrations.

Conclusion: Algorithms to calculate FT and bioT must be revalidated in the local setting, otherwise over- or underestimation of FT and bioT concentrations can occur. Additionally, confounding of the results by SHBG concentrations may be introduced.




The following articles in journals at HighWire Press have cited this article:


Home page
Ann Clin BiochemHome page
G. Sartorius, L. P Ly, K. Sikaris, R. McLachlan, and D. J Handelsman
Predictive accuracy and sources of variability in calculated free testosterone estimates
Ann Clin Biochem, March 1, 2009; 46(2): 137 - 143.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
J. A. Talbot, R. Sheldrick, H. Caswell, and S. Duncan
Sexual function in men with epilepsy: How important is testosterone?
Neurology, April 15, 2008; 70(16): 1346 - 1352.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
M. E. Kevenaar, J. S. E. Laven, S. L. Fong, A. G. Uitterlinden, F. H. de Jong, A. P. N. Themmen, and J. A. Visser
A Functional Anti-Mullerian Hormone Gene Polymorphism Is Associated with Follicle Number and Androgen Levels in Polycystic Ovary Syndrome Patients
J. Clin. Endocrinol. Metab., April 1, 2008; 93(4): 1310 - 1316.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
H. Dechaud, A. Denuziere, S. Rinaldi, J. Bocquet, H. Lejeune, and M. Pugeat
Age-Associated Discrepancy between Measured and Calculated Bioavailable Testosterone in Men
Clin. Chem., April 1, 2007; 53(4): 723 - 728.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2006 by the American Association for Clinical Chemistry.